Entering the golden age for antibody-drug conjugates in gynecologic cancer.

Greenman, Michelle; McNamara, Blair; Mutlu, Levent; Santin, Alessandro D

Greenman, Michelle; McNamara, Blair; Mutlu, Levent; Santin, Alessandro D.

Afiliação

Greenman M; Department of Obstetrics, Gynecology, and Reproductive Sciences, Yale University School of Medicine, New Haven, CT 06520, USA.
McNamara B; Department of Obstetrics, Gynecology, and Reproductive Sciences, Yale University School of Medicine, New Haven, CT 06520, USA.
Mutlu L; Department of Obstetrics, Gynecology, and Reproductive Sciences, Yale University School of Medicine, New Haven, CT 06520, USA.
Santin AD; Department of Obstetrics, Gynecology, and Reproductive Sciences, Yale University School of Medicine, New Haven, CT 06520, USA.

Oncoscience ; 11: 51-52, 2024.

Article em En | MEDLINE | ID: mdl-38770444

Palavras-chave

antibody-drug conjugates; gynecologic malignancies; precision medicine

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Oncoscience Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Estados Unidos País de publicação: Estados Unidos

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google